These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 20010163)
1. From the guest editor: the evolving treatment paradigm in multiple myeloma. Anderson KC Cancer J; 2009; 15(6):456. PubMed ID: 20010163 [No Abstract] [Full Text] [Related]
2. [Therapeutic outcomes in systemic lymphatic diseases and plasmacytoma. New hope for palliative patients]. Heinrich B MMW Fortschr Med; 2005 Jun; 147(24):23. PubMed ID: 16001528 [No Abstract] [Full Text] [Related]
4. Risk stratification in the era of novel therapies. San-Miguel J; Mateos MV; Gutierrez NC Cancer J; 2009; 15(6):457-64. PubMed ID: 20010164 [TBL] [Abstract][Full Text] [Related]
5. Evolving role of novel agents for maintenance therapy in myeloma. Magarotto V; Palumbo A Cancer J; 2009; 15(6):494-501. PubMed ID: 20010169 [TBL] [Abstract][Full Text] [Related]
7. Testicular invading refractory multiple myeloma during bortezomib treatment successfully treated with lenalidomide: a case report. Miyao K; Sakemura R; Sakai T; Tsushita N; Kato T; Niimi K; Ono Y; Sawa M Ann Hematol; 2014 Mar; 93(3):529-30. PubMed ID: 23820941 [No Abstract] [Full Text] [Related]
8. Clinical assessment of bortezomib for multiple myeloma in comparison with thalidomide. Satoh M; Oguro R; Yamanaka C; Takada K; Matsuura Y; Akiba T; Aotsuka N; Tani Y; Wakita H J Pharm Pharm Sci; 2011; 14(1):78-89. PubMed ID: 21501555 [TBL] [Abstract][Full Text] [Related]
9. Clinical management of myeloma--state of the art. Harousseau JL Cancer Treat Rev; 2010 May; 36 Suppl 2():S1-2. PubMed ID: 20472182 [TBL] [Abstract][Full Text] [Related]
10. New agents and approaches in the treatment of multiple myeloma. Anderson KC Clin Adv Hematol Oncol; 2003 Mar; 1(3):151-2. PubMed ID: 16224394 [No Abstract] [Full Text] [Related]
11. New developments in the treatment of patients with multiple myeloma. Minnema MC; van der Spek E; van de Donk NW; Lokhorst HM Neth J Med; 2010 Jan; 68(1):24-32. PubMed ID: 20103818 [TBL] [Abstract][Full Text] [Related]
12. Novel agents for relapsed and/or refractory multiple myeloma. Thomas SK; Richards TA; Weber DM Cancer J; 2009; 15(6):485-93. PubMed ID: 20010168 [TBL] [Abstract][Full Text] [Related]
13. Current status of new drugs for the treatment of patients with multiple myeloma. Kenealy M; Prince HM Intern Med J; 2006 Dec; 36(12):781-9. PubMed ID: 17096741 [TBL] [Abstract][Full Text] [Related]
15. [It is not necessary to use novel agents to all patients with newly diagnosed myeloma as an initial therapy]. Takamatsu Y Rinsho Ketsueki; 2012 Jun; 53(6):587-93. PubMed ID: 22790633 [No Abstract] [Full Text] [Related]
16. [New treatment strategy of multiple myeloma for cure]. Murakami H; Handa H Gan To Kagaku Ryoho; 2006 Apr; 33(4):417-23. PubMed ID: 16612147 [TBL] [Abstract][Full Text] [Related]